发明名称 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
摘要 The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.
申请公布号 US9637456(B2) 申请公布日期 2017.05.02
申请号 US201414770499 申请日期 2014.03.12
申请人 GlaxoSmithKline Intellectual Property (No. 2) Limited 发明人 Amans Dominique;Atkinson Stephen John;Harrison Lee Andrew;Hirst David Jonathan;Law Robert Peter;Lindon Matthew;Preston Alexander;Seal Jonathan Thomas;Wellaway Christopher Roland
分类号 C07D215/44;C07D401/12;A61K31/4709;A61K31/506;C07D401/14;C07D405/14;C07D413/14;C07D215/227;C07D215/46;C07D215/48;C07D401/04;C07D405/04;C07D409/12;C07D409/14;C07D413/04;C07D413/12;C07D417/12;C07D417/14;C07D471/04;C07D471/08;C07D487/08;C07D498/04;A61K31/4375;A61K31/4706;A61K31/496;A61K31/497;A61K31/5377;A61K31/5386;C07D498/08 主分类号 C07D215/44
代理机构 代理人 Fitch Duke M.;Lutomski Kathryn A.;Gimmi Edward R.
主权项 1. A compound which is (2S,3R,4R)-1-acetyl-2-cyclopropyl-3-methyl-4-((4-methylpyrimidin-2-yl)amino)-1,2,3,4-tetrahydroquinoline-6-carboxamide, represented by the formula: or a salt thereof.
地址 Brentford, Middlesex GB
您可能感兴趣的专利